Researchers in Hong Kong have revealed positive results from a trial involving a three-drug antiviral cocktail.
A new study, published on Friday in the medial journal The Lancet, said patients with milder forms of Covid-19 appeared to recover faster if they were given the treatment.
The study involved 127 adults, including 86 who were given the combination of three medicines: interferon beta-1b, opinavir-ritonavir and ribavirin.
The authors described the findings as “early but important” and have called for further research, including on more seriously ill patients.
“Our trial demonstrates that early treatment of mild to moderate Covid-19 with a triple combination of antiviral drugs may rapidly suppress the amount of virus in a patient’s body,” said Kwok-Yung Yuen, who led the research.
Source: BBC
